Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,584.04
(
0.27%
)
US TECH 100
29,529.20
(
0.36%
)
Dow Jones
50,971.16
(
0.60%
)
Brent Oil
91.31
(
-0.94%
)
Bitcoin
73,530.58
(
-0.01%
)
News Focus
News Focus

Replies to post #481192 on Anavex Life Sciences Corp (AVXL)

Replies to #481192 on Anavex Life Sciences Corp (AVXL)
icon url

abew4me

01/21/25 12:09 PM

#481193 RE: boi568 #481192

Well, assuming the FDA and EMA both accept just one primary endpoint, it shouldn't take that long to develop. Recruiting and screening is another headache...but once again, I was just looking at this from a worst-case scenario.
icon url

sab63090

01/21/25 1:12 PM

#481212 RE: boi568 #481192

boi568

👍️.........I guess I defer to you!
icon url

Doc328

01/21/25 1:39 PM

#481218 RE: boi568 #481192

2029 would be best case if trial started this quarter. 2030 would be more realistic since Missling did not start the trial in 2023